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Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease with alterations of colonic motility, which influence clinical symptoms. Although
morpho-functional abnormalities in the enteric nervous system have been suggested, in UC patients scarce attention has been paid to pos-
sible changes in the cells that control colonic motility, including myenteric neurons, glial cells and interstitial cells of Cajal (ICC). This study
evaluated the neural-glial components of myenteric ganglia and ICC in the colonic neuromuscular compartment of UC patients by quanti-
tative immunohistochemical analysis. Full-thickness archival samples of the left colon were collected from 10 patients with UC 
(5 males, 5 females; age range 45–62 years) who underwent elective bowel resection. The colonic neuromuscular compartment was
evaluated immunohistochemically in paraffin cross-sections. The distribution and number of neurons, glial cells and ICC were assessed by
anti-HuC/D, -S100 and -c-Kit antibodies, respectively. Data were compared with findings on archival samples of normal left colon from 
10 sex- and age-matched control patients, who underwent surgery for uncomplicated colon cancer. Compared to controls, patients with UC
showed: (i) reduced density of myenteric HuC/D neurons and S100 glial cells, with a loss over 61% and 38%, respectively, and
increased glial cell/neuron ratio; (ii) ICC decrease in the whole neuromuscular compartment. The quantitative variations of myenteric 
neuro-glial cells and ICC indicate considerable alterations of the colonic neuromuscular compartment in the setting of mucosal inflamma-
tion associated with UC, and provide a morphological basis for better understanding the motor abnormalities often observed in UC patients.
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Introduction
Ulcerative colitis (UC) is a chronic inflammatory bowel disorder
associated with functional changes, including abnormal colonic
motility and transit, which may contribute to abdominal pain and
diarrhoea [1–3] experienced by patients with active disease or in
remission [4]. These motor disturbances are suggestive of alter-
ations of colonic neuromuscular components, including enteric
neurons, interstitial cells of Cajal (ICC) and smooth muscle cells,
whose structural and functional integrity are essential require-
ments to ensure physiological patterns of coordinated motor
activity in the gut [5–8].
Although colonic dysmotility in UC patients has been well
established, scarce attention has been paid to underlying alter-
ations of the anatomical structures involved in the control of large
bowel neuromuscular activity. Furthermore, heterogeneous
methodological approaches, differing mainly in terms of histolog-
ical techniques (e.g. orientation and sectioning, ganglionic cell
counting, etc.), have been previously employed in evaluating the
enteric nervous system (ENS) in normal and UC colonic samples,
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thus yielding hardly comparable, or even conflicting, results.
Although some efforts have been previously made to obtain reli-
able quantitative estimations of ganglionic cells and ICC, careful
morphological examinations and development of standardized
protocols are still particularly required in the field of gastrointesti-
nal neuromuscular pathology, in order to overcome the hetero-
geneity of available data [9–11]. Based on the above considera-
tions, and following the recommendations issued by the
International Working Group on Gastrointestinal Neuromuscular
Disease [9, 10], we designed the present study, which was con-
ducted on left colonic samples from UC patients and control
patients, with the purpose of performing an accurate and stan-
dardized quantitative immunohistochemical analysis of the neural-
glial components of myenteric ganglia and ICC populations in this
gut region. Gaining knowledge in this setting is critical for a better
definition of mechanisms underlying colonic dysfunction in
patients with UC.
Materials and methods
Patients and tissue samples
The study was carried out on full-thickness archival samples of left
(descending and sigmoid) colon obtained from 10 patients (5 males, 
5 females; age range 45–62 years) with UC, who had undergone elective
bowel resection due to left-sided colitis from the dentate line to the splenic
flexure, lasting over 5 years. All patients had been scheduled for surgical
intervention owing to a persistent condition of refractoriness to immuno-
suppressant therapy and/or steroid dependence. The investigation was
focused on the left colon for two reasons: (1) normative values from oth-
erwise normal left-side colon have been previously published by our group
[12]; (2) to minimize inter-individual variability when comparing data from
different segments of the colon. Care was taken to select areas including
teniae with macroscopic involvement: the external surface appeared nor-
mal or slightly contracted, the mucosa diffusely congested, granular and
haemorrhagic with ulcers linearly distributed in particular at level of the
attachment of teniae. Archival colonic samples from ten patients (5 males,
5 females; age range 42–60 years), who had undergone surgery for
uncomplicated left colon cancer and without previous history of abdominal
surgery, inflammatory bowel disease or intestinal obstruction, served as
controls. Control samples were also selected from areas including teniae
at least 10 cm away from any macroscopically visible lesion. Because the
study was performed on archival material, no individual patient identifica-
tion was involved, and no study-driven clinical intervention was performed,
a simplified Institutional Review Board approval was obtained.
Routinely fixed and processed full-thickness colonic samples were
serially cross-sectioned to obtain 10 m-thick sections with circular layer
and myenteric ganglia cut longitudinally. Serial sections, 1/18 sections for
a distance of 180 m to prevent counting the same neuron in adjacent sec-
tions, were evaluated by two independent observers for each selected
colonic specimen. Before use, slides were deparaffinized, rehydrated and
processed for routine haematoxylin and eosin staining or immunohisto-
chemistry. The morphological features of the colon were assessed on
haematoxylin and eosin stained specimens by the pathologists (D.C.,
M.C.): the microscopic analysis of samples obtained from UC patients con-
firmed the presence of classical mucosal/submucosal lesions consistent
with UC as well as the occurrence of plexitis/ganglionitis in the myenteric
plexus of all UC patients according to previously published data [13, 14].
A normal morphology was detected in colonic samples from all control
patients.
Immunohistochemistry
Myenteric neurons, glial cells and ICC were identified by anti-HuC/D, anti-
S100 and anti-c-Kit antibodies, respectively. Antibody and reagent details
are reported in Table 1. 3,3-Diaminobenzidine tetrahydrochloride (DAB,
DakoCytomation, Glostrup, Denmark) and DAB enhanced with nickel chlo-
ride (10% nickel chloride; Sigma-Aldrich, St. Louis, MO, USA) were
employed as chromogen substrates to obtain brown and black reaction
products depending on protocols.
Primary antibodies Clone Host Dilution Code and source References
HuC/D MAb Mouse 1:100 A-21271, Molecular Probes, Eugene, OR, USA [19]
S100 MAb Mouse 1:2000 S2532, Sigma-Aldrich [35]
c-Kit (CD117) PAb Rabbit 1:200 A4502, DakoCytomation [36]
Secondary antibodies Host Dilution Code and source
Biotinylated antimouse IgG (H  L) Goat 1:200 BA-9200, Vector, Burlingame, CA, USA
Biotinylated anti-rabbit IgG (H  L) Goat 1:200 BA-1000, Vector
Biotinylated anti-rabbit, antimouse IgG
from LSAB®  System-HRP
Swine Ready to use K 0690, DakoCytomation
Table 1 Antibodies used in the present study
All primary antibodies were cross-reacting with the respective antigens of human origin. MAb: monoclonal antibody; PAb: polyclonal antibody.
HuC/D: human neuronal proteins HuC and HuD; S100: bovine S100 protein; c-Kit: human c-Kit (CD117); H  L: heavy and light chains; LSAB:
labelled streptavidin biotin; HRP: horseradish peroxidase.
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Negative controls for primary antibodies were obtained by omitting or
substituting them with preimmune rabbit or mouse serum (1:100).
Endogenous peroxidases were assayed by incubating slides with either DAB
alone or nickel enhanced-DAB alone. Avidin-binding activity was tested by
using streptavidin-horseradish peroxidase complex/DAB or /nickel enhanced-
DAB. All reactions were performed at room temperature and in humid cham-
bers, unless otherwise stated. Care was taken to select well oriented and well
stained microscopic fields for each immunostained structure of interest. Cell
counts were carried out by investigators blinded to the clinical diagnosis.
Identification and quantitative analysis 
of ganglion cells
To detect myenteric neurons and glial cells, a double immunolabelling with
anti-HuC/D and -S100 antibodies was performed as previously described
[12]. Briefly, after heat-induced epitope retrieval and non-specific binding
block, the following reagents were applied sequentially: primary antibodies
(anti-HuC/D and anti-S100), detection kit LSAB®  system-HRP and
chromogen substrate, which consisted of DAB and nickel enhanced-DAB
for HuC/D and S100, respectively.
Five cross-sections from one colonic specimen serially cut per patient
(1/18 sections) were examined as previously reported [12]: the first sec-
tion processed for immunohistochemistry was the 18th section after the
haematoxylin and eosin slice examined by the pathologists. For each sec-
tion, 30 non-adjacent randomly selected, microscopic fields, taken along
the myenteric ganglionic ridge, were examined in order to count immuno-
labelled cells and estimate the respective ganglionic areas, which were
expressed as a percentage of the respective microscopic field area.
Samples were examined at 400 magnification by a light microscope
equipped with a digital camera (DFC480; Leica, Cambridge, UK), and gan-
glionic areas were estimated by highlighting them using an Image Analysis
System Quantimet, Qwinv 500 plus (Cambridge Instruments, Cambridge,
UK). A ganglionic area of at least 1.4 mm2 was examined for each patient
and it was expressed as percentage of the total neuromuscular tissue area
examined (at least 10.35 mm2/each patient).
Neurons were counted when their nuclei and/or perikarya displayed
HuC/D signals, in order to avoid underestimation of neuronal number. For
each patient, the number of HuC/D neurons and S100 cells as well as
the respective ganglionic area percentage were expressed as sums (s) of
values obtained from examination of five serial sections (30 fields/section).
Cell density (cell number/mm2) and glial cell/neuron ratio were calculated
from the respective s values. Data from different patients or control
patients were also averaged and expressed as mean  S.D.
Identification and quantitative analysis 
of ICC and mast cells
c-Kit-immunolabelled ICC were revealed by nickel-DAB enhancement and
counterstained with nuclear fast red (Fluka, Buchs, Switzerland). Only c-
Kit cells with red nuclei were considered for ICC counting by means of a
squared grid. Strongly c-Kit-immunostained cells, with morphological
appearance and size of mast cells, were taken as internal positive controls,
excluded from the analysis of ICC and counted apart.
Five cross-sections (1/18 sections) for each colonic specimen were
examined. For each section, 30 randomly selected microscopic fields were
captured at 200 magnification. Ten fields were then focused on the
circular muscle (CM), 10 on the myenteric region (MP) and 10 on the lon-
gitudinal muscle (LM) to count ICC-CM, ICC-MP and ICC-LM, respectively.
The MP comprises the ridge of myenteric ganglia and the CM-LM interface
intercalated between ganglia; thus, ICC-MP counting included perigan-
glionic ICC located within the CM and LM bundles adjacent to myenteric
ganglia and interganglionic ICC. Each microscopic field was analysed by
the Qwinv 500 plus Quantimet System to obtain the accurate value of
immunolabelled tissue-covered areas.
For each patient, a total tissue area of at least 20 mm2 was examined
and partitioned in 0.5, 10.5 and 9.0 mm2 for MP, CM and LM, respectively.
The ICC density of each patient was expressed as ICC and mast
cells/tissue area found in the five serial sections (30 fields/section).
Quantitative determination of ICC area
The ICC area was estimated in serial sections adjacent to those used for cell
counting and subjected to nickel-DAB/c-Kit immunolabelling without
nuclear fast red counterstaining. For each section, 30 microscopic fields,
focused on the neuromuscular compartment, were captured at 200 mag-
nification and analysed by the Image Analysis System Quantimet (Qwinv
500 plus). Each field was subjected to intensity thresholding (from 150/255
to 185/255 depending on signal-to-noise ratio) in order to highlight the
immunoreactive area, which was expressed as percentage of the total tissue
area examined (percentage positive pixels [PPP]), according to Bettolli et al.
[15]. For each patient, the percentage of c-Kit area was expressed as mean
 S.D. of positive areas estimated on the 30 fields examined for each of five
sections (at least 20 mm2 of colonic tissue examined/patient). For each
group, the value of c-Kit area was expressed as mean  S.D. of individual
area percentages estimated in patients or control patients.
Statistical analysis
Linear regression analysis, performed by commercial software (GraphPad
Prism®, version 3.0; GraphPad Software, Inc., San Diego, CA, USA), was
employed to analyse correlation between ganglionic areas and the respec-
tive cell counts estimated for each slice within each patient and in different
patients. Student’s t-test for paired data (two tailed) was performed to




In control patients, neurons and associated glia formed a
homogeneous cluster of cells aggregated in well visualizable and
readily detectable myenteric ganglia showing normal appearance
(Fig. 1A). In the colon of UC patients, myenteric ganglia showed
several empty lacunar spaces, associated with depletion of
neuronal cell bodies, and some ganglia were ‘ectopic’, being
embedded within the CM or LM layers, outside from their typical
location (i.e. the MP) [16]. Signs of myenteric ganglionitis/
plexitis were observed in all UC samples and consisted of 
an inflammatory infiltrate (	4 cells) including eosinophils,
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lymphocytes or, occasionally, plasma cells adjacent to or within
myenteric ganglia or nerve bundles (Fig. 1B).
Immunohistochemistry
Myenteric neurons and glial cells
Neurons were identified by their HuC/D immunostained nucleus
and/or cytoplasm, and glial cells by a sharp nuclear/cytoplasmic
S100 immunoreaction. All control patients had colonic myen-
teric ganglia filled homogeneously with HuC/D-labelled neurons
and S100-labelled glial cells (Fig. 2A), whereas a loss of
myenteric neurons and glial cells was observed in UC patients
(Fig. 2B).
The mean of ganglionic area percentage, relative to the micro-
scopic field area, in UC patients (2.35  0.54%) was higher as
compared to controls (1.48  0.60%) with a significant increment
of 59% (individual values in Table 2). In control patients, the
mean values of neuron and glial cell density were 604.89 
29.65/mm2 and 2536.62  126.67/mm2, respectively, whereas in
the inflamed colon the respective values decreased significantly,
accounting for 237.56  59.93/mm2 and 1578.48 
258.14/mm2. A constant ratio between myenteric S100 glial
cells and HuC/D neurons was observed in control patients and
UC patients. In particular, the number of glial cells exceeded that
of neurons by approximately 4.19  0.10-fold in normal colon and
6.84  1.06-fold in UC, with a significant increment in UC (indi-
vidual and mean patients’ values are listed in Tables 2 and 3,
respectively).
Fig. 1 Haematoxylin and eosin stained sections showing myenteric ganglia
of full-thickness human left colon. (A) Control patient: a compact ganglion
with normal architecture, bulky neurons (arrowheads) and several glial
cells (arrows); (B) UC patient: a vacuolated ganglion with a few neurons
(red arrowheads) and glial cells (red arrows); two eosinophil granulocytes
(green arrowhead), one along the myenteric plexus (MP) region and one in
the CM; LM, longitudinal muscle. Scale bar: 50 m.
Fig. 2 Myenteric ganglia of full-thickness human left colon, in control
patients (A) and UC patients (B), double-immunostained with antibodies to
the neuronal marker HuC/D (brown) and the glial cell marker S100
(black): neuronal cell bodies (arrowheads) are reduced in number in UC
patients, as compared to controls. Scale bar: 50 m.
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Table 2 HuC/D neurons and S100 glial cells in myenteric ganglionic areas (mm2), respective densities and glial cell/neuron ratio in left
colonic samples from control patients (C) and UC patients (UC)
Neurons* Glial cells† Ganglionic area‡, (%)§ Neuron density# Glial cell density$ Glial cell/neuron ratio**
C
1 699 3039 1.238 (11.96) 564.62 2454.77 4.35
2 864 3566 1.299 (12.55) 665.13 2745.19 4.13
3 849 3652 1.355 (13.09) 626.57 2695.20 4.30
4 818 3425 1.397 (13.50) 585.54 2451.68 4.19
5 830 3546 1.436 (13.87) 577.99 2469.36 4.27
6 913 3899 1.482 (14.32) 616.06 2630.90 4.27
7 934 3841 1.553 (15.00) 601.42 2473.28 4.11
8 1015 4248 1.616 (15.61) 628.09 2628.71 4.19
9 978 3956 1.670 (16.14) 585.63 2368.86 4.04
10 1023 4189 1.711 (16.53) 597.90 2448.28 4.09
UC
11 462 3288 1.622 (15.67) 284.77 2027.07 7.12
12 534 3290 1.706 (16.49) 312.73 1927.92 6.16
13 372 2672 1.774 (17.14) 209.72 1506.52 7.18
14 519 3082 2.085 (20.15) 248.72 1477.88 5.94
15 391 3272 2.341 (22.62) 166.98 1397.37 8.37
16 409 3354 2.465 (23.82) 165.93 1360.70 8.20
17 486 3829 2.581 (24.94) 188.28 1483.26 7.88
18 878 4901 2.766 (26.72) 317.62 1772.16 5.58
19 579 3650 3.006 (29.05) 192.60 1214.16 6.30
20 897 5036 3.113 (30.08) 288.28 1617.70 5.61
*, †, ‡Values corresponding to the  of 30 fields of five sections/patient; ‡ganglionic areas expressed in mm2; §percentage ganglionic area/field
area; #neurons/ganglionic area; $glial cells/ganglionic area and **glial cell density/neuron density.
Table 3 Density of myenteric neurons (N) and glial cells (GC), ICC and mast cells in the neuromuscular compartment of left colon in control
patients (C) and UC patients (UC)
Marker Cell type C UC P
HuC/D N 604.89  29.65 237.56  59.93 	0.0001
S100 GC 2536.62  126.67 1578.48  258.14 	0.0001
c-Kit ICC-CM 135.60  9.95 30.26  11.17 	0.0001
c-Kit ICC-MP 1054.07  115.20 362.46  88.92 	0.0001
c-Kit ICC-LM 127.90  14.15 45.62  11.04 	0.0001
c-Kit Mast cells-CM 1.98  0.89 5.14  1.74 	0.001
c-Kit Mast cells-MP 0.20  0.32 12.99  4.16 	0.0001
c-Kit Mast cells-LM 4.89  1.94 18.27  2.67 	0.0001
CM (circular muscle), MP (myenteric plexus), LM (longitudinal muscle); values are expressed as mean  S.D. of cell density (cell number/mm2);
a P-value 	0.05 was considered statistically significant by Student’s t-test (UC versus controls).
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Data obtained from neuron and glial cell counting were analysed
by linear regression. Significant correlations between neuron or
glial cell counts and the respective ganglionic areas were observed
in all control patients, whereas only two UC patients showed signif-
icant correlation for neurons and seven patients for glial cells 
(Fig. S1; Table S1). Linear regression analysis among patients
showed that neuron density correlated significantly both in 
controls (r 
 0.918, P 
 0.0002) and UC patients (r 
 0.632, 
P 
 0.0496). Likewise, significant correlations were found for glial
cell density in control patients (r 
 0.890, P 
 0.0006) and UC
patients (r 
 0.754, P 
 0.0117) (Fig. S2).
c-Kit cells: ICC and mast cells
A marked c-Kit immunoreaction was detected in the ICC of
neuromuscular layer and mast cells (used as internal controls)
(Fig. 3A). In colonic specimens from control patients, c-Kit
immunoreactive ICC appeared as dendritic cell bodies typically
located within the CM (ICC-CM) and LM (ICC-LM) layers as well
as in the MP (ICC-MP) (Figs 3, 4A, D, G and 5A). Intramuscular
ICC were spindle-shaped cells with long bipolar processes mostly
running parallel to the axis of smooth muscle cells (Fig. 3B). In the
intermuscular region, ICC-MP appeared as multipolar cells and
formed a network encasing the myenteric ganglia (Figs 3C 
and 4D). In colonic samples from UC patients, the overall
morphological appearance and distribution pattern of ICC were
markedly altered: the c-Kit network was rarefied and often
disrupted in each layer, and most of ICC displayed considerable
morphological alterations with blunted and shortened branching
(Figs 4B, E, H and 5B).
Only the c-Kit spindle- and/or dendritic-shaped cells with a
nuclear fast red counterstained nucleus (Fig. 4) were considered
for ICC counting and density estimation. The overall ICC density
within the neuromuscular compartment was 1317/mm2 in control
colon, with a significant decrease to 438/mm2 in UC, and ICC
counting carried out separately within each layer allowed to
observe a significant decrease in ICC density at every level in UC
patients. In particular, the highest density of ICC in control colon
was found within the myenteric plexus region (1054.07 
115.20/mm2), followed by the CM (135.60  9.95/mm2) and LM
(127.90  14.15/mm2) layers. In UC patients the ICC density was
362.46  88.92/mm2 in the MP, 30.26  11.17 and 45.62 
11.04/mm2 in the CM and LM layers, respectively (Fig. 4C, F, I;
Table 3). On the other hand, increased numbers of mast cells were
found within the whole neuromuscular compartment of UC
patients versus controls with the following density values: myen-
teric plexus region (12.99  4.16 versus 0.20  0.32/mm2), CM
(5.14  1.74 versus 1.98  0.89/mm2) and LM (18.27  2.67
versus 4.89  1.94/mm2) layers (Table 3).
Quantitative analysis of the area covered by ICC was per-
formed on c-Kit immunostained slides without counterstaining
(Fig. 5A, B). A significant decrease in ICC area was observed 
in UC patients, in whom ICC covered an area corresponding to
0.62  0.18%, as compared to 3.49  0.94% detected in control
patients (Fig. 5C).
Discussion
Enteric neurons and glial cells, together with ICC, represent the
main regulators of motor functions in the gut wall, ensuring coor-
dinated patterns of smooth muscle activity [1, 3]. This carefully
regulated neural/myogenic network is markedly altered in the 
setting of bowel inflammation, resulting in gut dismotility [5, 17].
However, despite the increasing incidence of UC and its debilitat-
ing symptoms, few studies have evaluated the occurrence of
morphological alterations in the anatomical structures regulating
colonic motility. Previous histopathological data suggested that
the ENS and ICC can be targeted by the inflammatory disease in
patients with UC [14, 17, 18]. However, there is also evidence
suggesting that a primary damage to the enteric glia can cause
Fig. 3 Full-thickness normal human left colon immunostained for c-Kit to
detect the ICC (black stain), counterstained with nuclear fast red. ICC (A) are
typically distributed within the CM (ICC-CM) and LM (ICC-LM) layers as well
as along the MP (ICC-MP); markedly immunoreactive mast cells are pres-
ent in the external muscular layer (arrows) (B) a bipolar ICC orientated along
the main axis of smooth muscle cells in the circular layer (C) a representa-
tive example illustrating ICC-MP with their numerous processes in the
myenteric plexus (MP) region. Scale bars: 50 m (A) and 25 m (B, C).
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inflammatory bowel disease, leading to secondary alterations of
enteric neurons [19]. The present study was performed to examine
the cell composition of myenteric ganglia and ICC distribution in
the colon of UC patients in accordance with recently identified
technical and methodological criteria of crucial importance for a
correct interpretation of neuronal-glia-ICC data [9, 10].
Significant quantitative changes in both myenteric ganglia
and ICC were detected by our analysis. Myenteric ganglia were
markedly altered in all colonic samples from UC patients. In
accordance with previous reports [13], there was a ganglionic
vacuolization associated with depletion of neurons and glial cells
and a minimal inflammatory infiltration. In particular, the density
of HuC/D neurons was significantly decreased by about 61%
and S100 glial cells by about 38%. These data are at variance
with those by Villanacci et al. [18], who showed that in UC the
number of myenteric neurons did not change significantly.
However, this discrepancy can be explained by several reasons:
(1) the enrolled patients were younger than those included in 
our study (i.e. 35–52 versus 45–62 years); (2) neuron-specific
enolase was used as neuronal marker and (3) neuronal density
Fig. 4 Evaluation of distribution, morphology (A, B, D, E, G, H) and counting (C, F, I) of c-Kit immunolabelled and nuclear fast red-counterstained ICC
(black) at the level of CM (ICC-CM) and LM (ICC-LM) layers, and the myenteric plexus region (ICC-MP) of full-thickness human left colon in control
patients (A, D, G) and UC patients (B, E, H). In colonic specimens from UC patients, few ICC are detectable and they appear markedly altered: most of
them exhibit blunted and shortened branching (B, E, H). Column graphs display ICC counting (white: control, black: UC) which is given as means  S.D.
of individual ICC densities normalized to area (mm2) for ICC-CM (C), ICC-MP (F) and ICC-LM (I). ***P 	 0.0001 versus control. Scale bar: 50 m.
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was referred to microscopic field areas. In contrast, in our study,
HuC/D was preferred over other pan-neuronal markers, as it
labels selectively the neural cell bodies, thus increasing the
accuracy of quantitative analysis by avoiding confounding fac-
tors such as neuropil and nerve endings [10, 12, 20–22], and it
has been included among the neuronal markers recommended
for immunohistochemical studies of gastrointestinal neuromuscu-
lar diseases [9]. Despite these advantages, HuC/D is a marker
which stains one single protein, and this limitation may result in
inflated estimates of enteric neuronal loss, particularly in aged 
tissues, as suggested by Phillips et al. [23], who studied enteric
neurons from aged rats. In accordance with these findings, differ-
ent degrees of HuC/D labelling were recorded also in myenteric
neurons of the patients evaluated both in the present study and a
previous one from our group [12]. Although the sensitivity of
HuC/D immunostaining, extensively tested together with the pan-
neuronal cuprolic blue, is considered to be equivalent to cuprolic
blue for enteric neuronal quantification [12, 21, 22, 24], we cannot
certainly rule out that some neurons failed to express the HuC/D
protein due to aging. According to the present findings, the
glia/neuron ratio ranged from 3.72 to 4.19, a value lower than that
estimated in previous reports (5.9–8.7) [25–27]. Again, such
apparent discrepancies might depend on different criteria for cell
counts. The present analysis included also neurons with HuC/D
cytoplasm without a visible nucleus and glial cells specifically
labelled for S100 antigen, whereas in previous studies ganglionic
cells were identified either as neurons when clearly nucleated, or as
glial cells when endowed with small basophil nuclei.
In our study, correlations between myenteric cell counts and the
respective ganglionic areas were found for each control patient, but
not for all UC patients. In particular, significant correlations were
obtained only in two patients for neurons and seven patients for glial
cells. In addition, the overall regression analysis of cell density for
each group yielded highly significant values for neurons and glial
cells in the control group, whereas few significant values, in partic-
ular for neurons, were obtained in UC patients. Taken together, these
data suggest that neuronal rather than glial cell density was more
affected in the UC patients herein examined. The present findings
raise the important question of whether the neuronal loss in UC
involves indiscriminately all myenteric neurons or selectively affects
specific subsets. In a previous study on UC, Neunlist et al. [28]
found a neurochemical phenotype shift from acetylcholine to sub-
stance P. However, when studying trinitrobenzene sulphonate
(TNBS)-induced colitis in guinea-pigs, Linden et al. [29] observed
an indiscriminate loss of myenteric neurons. Overall, this is a very
important issue, which has not been addressed in the present study
and remains open to future investigations.
ENS abnormalities, underlying gut motility disorders, are often
associated with altered density, distribution and/or morphology of
ICC [30]. Accordingly, we found marked morphological and quan-
titative alterations of ICC in all UC patients. Indeed, all ICC types
(ICC-CM, ICC-LM and ICC-MP) were significantly decreased by
over 50%, as compared to control patients. These results, which
are at variance with previous reports showing an increased 
number of intramuscular ICC and unchanged ICC-MP in UC colon
[14, 18], might be explained by differences in patients’ population,
segments of colon examined and morphometric approaches. The
decrease in c-Kit labelled cells identifiable as ICC, as observed in
our UC colonic tissues, might also result from an actual loss of ICC
or a mere loss of their c-Kit reactivity, a dilemma which could be
resolved only by means of transmission electron microscopy. Of
interest, our morphological approach revealed that most of the ICC
Fig. 5 Neuromuscular compartment of full-thickness human left colon: 
c-Kit-nickel-DAB immunostaining to evaluate ICC area in colonic sections
from control patients (A) and UC patients (B). Quantitative image analysis
(C) of c-Kit immunoreactivity is expressed as PPP in control patients (white
column) and UC patients (black column). Column graphs display the 
mean  S.D. of individual values for each group. ****P 	 0.00001 
versus control. Scale bar: 50 m.
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displayed blunted and shortened branching. These morphological
alterations, together with reduction in the number of these cells,
might contribute to a malfunctioning network. An attempt to assess
ICC structural abnormalities in the colon of UC patients has been
previously made by Rumessen [8] who, however, focused his eval-
uations only on submuscular ICC. Using electron microscopy, this
author found that ICC had large intracytoplasmatic bodies. Briefly,
our data do not allow explaining whether ICC abnormalities in UC
patients result from direct effects of inflammatory mediators [14,
17, 18], secondary changes reflecting primary glial damage [19] or
inflammatory-related remodelling processes, thereby leading to
alterations in the mechanical properties of colonic wall.
Whether mast cells play also an active role in the pathophysi-
ology of inflammation in UC remains to be determined. This is a
relevant issue, because in the human gut mast cells are involved
in the maintenance of intramuscular ICC viability, through
paracrine production of the stem cell factor, which acts as a ligand
for the c-Kit receptor [31]. In addition, mast cells can contribute
to fibrogenesis and neuroplasticity [32] and possible functional
interactions between mast cells and ICC have been suggested in
intestinal muscularis externa [33]. However, these cells have been
also found to reduce myenteric neuron survival in culture [34]. In
the present study, we observed increased numbers of mast cells
within the colonic neuromuscular compartment. These findings
are in line with previous studies showing a significantly increased
mast cell density in the colonic muscle layer of UC patients [32].
In conclusion, the present findings provide a thorough mor-
phological and quantitative analysis showing changes in myen-
teric neurons, glial cells and ICC in the left colon of patients with
UC. Because these cells play critical roles in the regulation of
colonic functions, including motility, our data on enteric neuronal-
glia-ICC network abnormalities shed light on the mechanisms
underlying gut dysfunctions observed in the subset of UC patients
with long-lasting chronic disease.
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